Company
United StatesPublic company, NYSE: ABTAbbott Laboratories (NYSE: ABT), Columbus, OH – FDA Inspections
Inspection records and compliance data for Abbott Laboratories in Columbus, Ohio. 3 FDA inspections on record, last inspected May 10, 2023. Publicly traded as NYSE: ABT.
Company Profile
This profile covers Abbott Laboratories based in Columbus, Ohio, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected September 12, 2013. Last inspected May 10, 2023.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 10, 2023 | Not classified | Foods & Cosmetics | 1206874 |
| August 29, 2017 | NAI | Foods & Cosmetics · Pesticides and Chemical Contaminants | 1024135 |
| September 12, 2013 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 848029 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Abbott Laboratories
Stock ticker
ABT
Exchange
NYSE
Share price
$113.74
Market cap
$197.0B
Price as of
November 6, 2026
FEI Number
1527470
Address
350 N 5th St, Columbus, Ohio 43215, United States
Country
United States
ID: 9fcededd-544a-4bd6-9312-f017d92734a0